Mattew L Anderson

Matthew L. Anderson serves as a Contract Specialist within the Defense Health Agency (DHA), supporting the procurement of critical healthcare services and infrastructure essential to operational readiness across the Department of Defense. In this role, he manages the full lifecycle of acquisition activities, from requirement validation and market research to contract award and administration, with a primary focus on direct health and medical insurance carriers. His work ensures seamless delivery of medical benefits and support services to active-duty personnel, retirees, and their families, aligning procurement outcomes with DHA’s strategic priorities in clinical quality, pharmaceutical supply chain resilience, and health data security. Anderson maintains consistent working relationships with a core group of contractors including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc., all of which provide specialized medical, technical, and administrative services. His procurement patterns reflect a preference for established vendors with proven capabilities in healthcare compliance, secure data handling, and clinical support systems, fostering long-term partnerships grounded in performance reliability and regulatory adherence. Notably, Anderson’s acquisition portfolio exhibits no set-aside preferences, with 100% of contracts awarded under full and open competition. This reflects a strategic emphasis on leveraging broad market capability rather than socioeconomic classifications, prioritizing mission-critical outcomes over categorical set-asides. His primary NAICS classification is 524114 (Direct Health and Medical Insurance Carriers), indicating deep specialization in procuring managed care, TRICARE support services, and related health plan administration. Anderson’s expertise centers on complex healthcare delivery systems, including insurance contracting, provider network management, and integrated health benefits administration, ensuring DHA’s global medical infrastructure remains agile, compliant, and responsive to evolving operational needs.